BND vs AGG: returns, risk and drawdowns compared
Vanguard Total Bond Market ETF against iShares Core U.S. Aggregate Bond ETF, over the same 19 years (May 2007 to November 2026) with dividends reinvested.
Data updated November 2026
BND
Vanguard Total Bond Market ETF
10,000 became
17,535
- A year on average
- +2.9%
- Annual volatility
- 4.6%
- Deepest fall
- −17.5%
- Worst month
- −4.2%
AGG
iShares Core U.S. Aggregate Bond ETF
10,000 became
17,219
- A year on average
- +2.8%
- Annual volatility
- 4.6%
- Deepest fall
- −17.1%
- Worst month
- −4.1%
BND came out ahead by 0.1 percentage points a year from May 2007 to November 2026. AGG swung more (4.6% against 4.6% a year). The correlation of monthly returns was 0.98: they moved almost in lockstep.
Growth of 10,000: BND vs AGG
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero BND had returned more, below zero AGG. BND was ahead in 58% of the 200 three-year periods.
Annualised 3-year return of BND minus that of AGG, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: BND −17.5%, AGG −17.1%.
All the figures
| BND | AGG | |
|---|---|---|
| Annual return (CAGR) | +2.9% | +2.8% |
| Total return | +75% | +72% |
| Annual volatility | 4.6% | 4.6% |
| Deepest fall (month-end) | −17.5% | −17.1% |
| Worst month | −4.2% | −4.1% |
| Best month | +5.1% | +6.7% |
| Positive months | 60% | 58% |
| Best year | 2019: +8.8% | 2019: +8.5% |
| Worst year | 2022: −13.1% | 2022: −13.0% |
| 1-year return | −0.3% | −1.1% |
| 5 years, a year | −0.3% | −0.3% |
| 10 years, a year | +1.6% | +1.5% |
| Trading currency | USD | USD |
First nine rows: the same 235 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half BND, half AGG
| BND alone | AGG alone | 50/50 | |
|---|---|---|---|
| A year on average | +2.9% | +2.8% | +2.9% |
| Annual volatility | 4.6% | 4.6% | 4.6% |
| Deepest fall (month-end) | −17.5% | −17.1% | −17.3% |
| Worst month | −4.2% | −4.1% | −4.2% |
With a correlation of 0.98 the mix behaved almost like either fund alone: its volatility of 4.6% sits between the two. Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, BND or AGG?
From May 2007 to November 2026, BND returned +2.9% a year and AGG +2.8% a year, with dividends reinvested. Over rolling 3-year periods BND did better in 58% of cases. Past returns do not predict future returns.
Which is riskier, BND or AGG?
Over the same months annual volatility was 4.6% for BND and 4.6% for AGG; the deepest fall from a month-end high was 17.5% and 17.1%, and the worst single month −4.2% and −4.1%.
How correlated are BND and AGG?
The correlation of their monthly returns was 0.98: they moved almost in lockstep. Holding both adds little diversification compared with holding one.
What about holding both BND and AGG?
Half in each, rebalanced every month, returned +2.9% a year over the same period, with 4.6% annual volatility and a deepest month-end fall of 17.3%.
More comparisons
- BND — Vanguard Total Bond Market ETFReturns, drawdowns and risk
- AGG — iShares Core U.S. Aggregate Bond ETFReturns, drawdowns and risk
- BND vs AGGH
- BND vs BNDX
- AGG vs AGGH
- AGG vs BNDX
- What a crisis would do to your portfolioYour own scenarios, holding by holding
- Portfolio analytics software comparedFeatures and prices side by side
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.